Glen Clova Scientific Announces Clinical Advisory Board for its Immuno-Dermatology Pipeline
Dundee, UK, 09 October 2025 – Glen Clova Scientific (GCS), a biotechnology company developing breakthrough therapeutics for treatment of immuno-dermatological conditions, is pleased to announce the establishment of its Clinical Advisory Board (CAB).
